The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective
Abstract
Curtis C. Harris; COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective, Carcinogenesis, Vo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Self-citationGenetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H., Lin, H., Liebermann, D. A., Hoffman‐Liebermann, B., & Reed, J. C. (1994) · PubMed · Cited by 2,143
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Self-citationControl of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
Self-citationmdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., & Vogelstein, B. (1990) · PubMed · Cited by 1,063
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., & Van Dyke, T. (1994) · Cell · doi:10.1016/0092-8674(94)90534-7 · Cited by 880
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8493 · Cited by 858
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., & Costa, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4495 · Cited by 848
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
Caelles, C., Helmberg, A., & Karin, M. (1994) · Nature · doi:10.1038/370220a0 · Cited by 843
Sarnow, P., Ho, Y. S., Williams, J., & Levine, A. J. (1982) · Cell · doi:10.1016/0092-8674(82)90356-7 · Cited by 836
Abnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Presence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
p53 functions as a cell cycle control protein in osteosarcomas.
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 772
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
A transcriptionally active DNA-binding site for human p53 protein complexes.
Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., & Shay, J. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2866 · Cited by 732
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
Parada, L. F., Land, H., Weinberg, R. A., Wolf, D., & Rotter, V. (1984) · Nature · doi:10.1038/312649a0 · Cited by 730
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Thor, A. D., Moore, D. H., Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L.-C., Mayall, B. H., et al. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.11.845 · Cited by 723
DeLeo, A. B., Jay, G., Appella, E., Dubois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
Eliyahu, D., Raz, A., Gruss, P., Givol, D., & Oren, M. (1984) · Nature · doi:10.1038/312646a0 · Cited by 717
Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 692
Gannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688
Clonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Self-citationA p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Brennan, J. A., Boyle, J. O., Koch, W. M., Goodman, S. N., Hruban, R. H., Eby, Y. J., Couch, M. J., Forastiere, A. A., & Sidransky, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321104 · Cited by 658
Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene
Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 619
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
Morgenbesser, S. D., Williams, B. O., Jacks, T., & DePinho, R. A. (1994) · Nature · doi:10.1038/371072a0 · Cited by 610
A subset of p53-deficient embryos exhibit exencephaly
Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., & Jacks, T. (1995) · Nature Genetics · doi:10.1038/ng0695-175 · Cited by 580
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579
Hinds, P., Finlay, C., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 577
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53
Jenkins, J. R., Rudge, K., & Currie, G. A. (1984) · Nature · doi:10.1038/312651a0 · Cited by 552
Crystal Structure of the Tetramerization Domain of the p53 Tumor Suppressor at 1.7 Angstroms
Jeffrey, P. D., Gorina, S., & Pavletich, N. P. (1995) · Science · doi:10.1126/science.7878469 · Cited by 549
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542
Wagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 539
Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
Martinez, J., Georgoff, I., Martinez, J., & Levine, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.2.151 · Cited by 527
Genetic Mechanisms of Tumor Suppression by the Human p53 Gene
Chen, P.-L., Chen, Y., Bookstein, R., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2274789 · Cited by 518
Crook, T., Vousden, K. H., & Tidy, J. A. (1991) · Cell · doi:10.1016/0092-8674(91)90529-8 · Cited by 505
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A. J., & Shenk, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504
Levine, A. J. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.003203 · Cited by 500
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan, S., Smith, M. L., Rivet, D. J., Duba, D. E., Zhan, Q., Kohn, K. W., Fornace, A. J., & O'Connor, P. M. (1995) · PubMed · Cited by 490
Localization of gene for human p53 tumour antigen to band 17p13
Isobe, M., Emanuel, B. S., Givol, D., Oren, M., & Croce, C. M. (1986) · Nature · doi:10.1038/320084a0 · Cited by 485
Yokota, J., Wada, M., Shimosato, Y., Terada, M., & Sugimura, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9252 · Cited by 480
Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H., Krajewski, S., Reed, J., Hoffman‐Liebermann, B., & Liebermann, D. A. (1994) · PubMed · Cited by 478
Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Appella, E., Romano, J. W., & Ullrich, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6166 · Cited by 477
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2442 · Cited by 469
Self-citationHigh-frequency developmental abnormalities in p53-deficient mice
Armstrong, J. F., Kaufman, M. H., Harrison, D. J., & Clarke, A. R. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00183-7 · Cited by 467
Kilbourn, R. G., & Belloni, P. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.9.772 · Cited by 465
Kemp, C. J., Donehower, L. A., Bradley, A., & Balmain, A. (1993) · Cell · doi:10.1016/0092-8674(93)90461-x · Cited by 457
Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
Okamoto, K., & Beach, D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06807.x · Cited by 455
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
Crawford, L. V., Pim, D. C., & Bulbrook, R. D. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300404 · Cited by 450
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439
Wild-type p53 can down-modulate the activity of various promoters.
Ginsberg, D., Mechta, F., Yaniv, M., & Oren, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9979 · Cited by 435
Small peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434
Lees-Miller, S. P., Chen, Y. R., & Anderson, C. W. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6472 · Cited by 417
Wolf, D., & Rotter, V (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.790 · Cited by 410
Sequence-specific transcriptional activation is essential for growth suppression by p53.
Pietenpol, J. A., Tokino, T., Thiagalingam, S., el-Deiry, W. S., Kinzler, K. W., & Vogelstein, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.1998 · Cited by 406
Lee, S., Elenbaas, B., Levine, A., & Griffith, J. (1995) · Cell · doi:10.1016/s0092-8674(05)80006-6 · Cited by 405
Pan, H., & Griep, A. E. (1994) · Genes & Development · doi:10.1101/gad.8.11.1285 · Cited by 404
Pietenpol, J. A., Holt, J. T., Stein, R. W., & Moses, H. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3758 · Cited by 398
Lavigueur, A., Maltby, V, Mock, D., Rossant, J., Pawson, T., & Bernstein, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3982 · Cited by 394
Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.
Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., & Doshi, H. M. (1992) · PubMed · Cited by 383
Santhanam, U., Ray, A., & Sehgal, P. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7605 · Cited by 375
Inhibition of DNA replication factor RPA by p53
Dutta, A., Ruppert, J. M., Aster, J. C., & Winchester, E. (1993) · Nature · doi:10.1038/365079a0 · Cited by 374
p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis
Kemp, C. J., Wheldon, T., & Balmain, A. (1994) · Nature Genetics · doi:10.1038/ng0994-66 · Cited by 368
Bargonetti, J., Friedman, P. N., Kern, S. E., Vogelstein, B., & Prives, C. (1991) · Cell · doi:10.1016/0092-8674(91)90560-l · Cited by 367
Functional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Hunter, T. (1993) · Cell · doi:10.1016/0092-8674(93)90528-x · Cited by 366
Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.
Smith, M. L., Chen, I. T., Zhan, Q., O'Connor, P. M., & Fornace, A. J. (1995) · PubMed · Cited by 364
Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53.
Xiao, H., Pearson, A., Coulombe, B., Truant, R., Zhang, S., Regier, J. L., Triezenberg, S. J., Reinberg, D., Flores, O., & Ingles, C. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.7013 · Cited by 361
Kress, M., May, E., Cassingena, R., & May, P. (1979) · Journal of Virology · doi:10.1128/jvi.31.2.472-483.1979 · Cited by 359
Ford, J. M., & Hanawalt, P. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8876 · Cited by 346
Jayaraman, L., & Prives, C. (1995) · Cell · doi:10.1016/s0092-8674(05)80007-8 · Cited by 345
Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
Bischoff, J. R., Friedman, P. N., Marshak, D. R., Prives, C., & Beach, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4766 · Cited by 342
Specific interaction between the p53 cellular tumour antigen and major heat shock proteins
Pinhasi-Kimhi, O., Michalovitz, D., Ben-Zeev, A., & Oren, M. (1986) · Nature · doi:10.1038/320182a0 · Cited by 329
Li, R., & Botchan, M. R. (1993) · Cell · doi:10.1016/0092-8674(93)90649-b · Cited by 324
p53 expression and prognosis in gastric carcinoma
Martin, H. M., Filipe, M. I., Morris, R. W., Lane, D. P., & Silvestre, F. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500604 · Cited by 321
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
Mowat, M., Cheng, A., Kimura, N., Bernstein, A., & Benchimol, S. (1985) · Nature · doi:10.1038/314633a0 · Cited by 320
Serum p53 antibodies as early markers of lung cancer
Lubin, R., Zalcman, G., Bouchet, L., Trédaniel, J., Legros, Y., Cazals, D., Hirsch, A., & Soussi, T. (1995) · Nature Medicine · doi:10.1038/nm0795-701 · Cited by 318
Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
Vahakangas, K. H., Metcalf, R. A., Welsh, J. A., Bennett, W. P., Harris, C. C., Samet, J. M., & Lane, D. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90866-2 · Cited by 316
Self-citationZambetti, G. P., Bargonetti, J., Walker, K., Prives, C., & Levine, A. J. (1992) · Genes & Development · doi:10.1101/gad.6.7.1143 · Cited by 311
EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G., & Wiman, K. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5455 · Cited by 309
Feitelson, M. A., Zhu, M., Duan, L., & London, W. T. (1993) · PubMed · Cited by 307
Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G., Albert, D. M., & Windle, J. J. (1994) · Genes & Development · doi:10.1101/gad.8.11.1300 · Cited by 303
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M., & Vousden, K. H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00418.x · Cited by 301
Human TAFII31 protein is a transcriptional coactivator of the p53 protein.
Lu, H., & Levine, A. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5154 · Cited by 301
Lotem, J., & Sachs, L. (1993) · Blood · doi:10.1182/blood.v82.4.1092.1092 · Cited by 301
Evidence for a second cell cycle block at G2/M by p53.
Stewart, N., Hicks, G. G., PARASKEVAS, F., & Mowat, M. R. A. (1995) · PubMed · Cited by 300
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
Matlashewski, G., Lamb, P., Pim, D., Peacock, J., Crawford, L., & Benchimol, S. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02287.x · Cited by 299
Slow Repair of Pyrimidine Dimers at p53 Mutation Hotspots in Skin Cancer
Tornaletti, S., & Pfeifer, G. P. (1994) · Science · doi:10.1126/science.8128225 · Cited by 296
Baudier, J., Delphin, C., Grunwald, D., Khochbin, S., & Lawrence, J. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11627 · Cited by 285
Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284
p53 and DNA polymerase α compete for binding to SV40 T antigen
Gannon, J. V., & Lane, D. P. (1987) · Nature · doi:10.1038/329456a0 · Cited by 282
p53 point mutation in HPV negative human cervical carcinoma cell lines.
Crook, T., Wrede, C. D., & Vousden, K. H. (1991) · PubMed · Cited by 272
Powell, S. N., DeFrank, J. S., Connell, P., Eogan, M., Preffer, F., Dombkowski, D., Tang, W., & Friend, S. H. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)97825-l · Cited by 268
Liu, X., Miller, C. W., Koeffler, P. H., & Berk, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3291 · Cited by 260
Houbiers, J. G. A., Nijman, H. W., Van Der Burg, S. H., Drijfhout, J. W., Kenemans, P., Van De Velde, C. J. H., Brand, A., Momburg, F., Kast, W. M., & Melief, C. J. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230905 · Cited by 258
Milne, D. M., Campbell, L. E., Campbell, D. G., & Meek, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5511 · Cited by 257
Truant, R., Antunovic, J., Greenblatt, J., Prives, C., & Cromlish, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1851-1859.1995 · Cited by 255
Mercer, W. E., Nelson, D., DeLeo, A. B., Old, L. J., & Baserga, R. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6309 · Cited by 255
Bischoff, F. Z., Yim, S. O., Pathak, S., Grant, G., Siciliano, M. J., Giovanella, B. C., Strong, L. C., & Tainsky, M. A. (1990) · PubMed · Cited by 252
Rogan, E. M., Bryan, T. M., Hukku, B., Maclean, K., Chang, A. C.-M., Moy, E. L., Englezou, A., Warneford, S. G., Dalla-Pozza, L., & Reddel, R. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4745 · Cited by 250
Wolf, D., Harris, N., & Rotter, V. (1984) · Cell · doi:10.1016/0092-8674(84)90532-4 · Cited by 249
Mercer, W. E., Shields, M. T., Lin, D., Appella, E., & Ullrich, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1958 · Cited by 249
Khanna, K. K., & Lavin, M. F. (1993) · PubMed · Cited by 245
p53 expression in colorectal tumors.
Purdie, C. A., O’Grady, J., Piris, J., Wyllie, A. H., & Bird, C. (1991) · PubMed Central · Cited by 240
ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS
Mackay, J., Elder, P., Steel, C. M., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90584-3 · Cited by 236
Weston, A., Willey, J. C., Modali, R., Sugimura, H., McDowell, E. M., Resau, J., Light, B., Haugen, A., Mann, D. L., & Trump, B. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.5099 · Cited by 235
Transcriptional activation by p53 correlates with suppression of growth but not transformation
CROOK, T. (1994) · Cell · doi:10.1016/0092-8674(94)90071-x · Cited by 233
Hinds, P. W., Finlay, C. A., Frey, A. B., & Levine, A. J. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2863 · Cited by 232
Harvey, M., Vogel, H., Morris, D., Bradley, A., Bernstein, A., & Donehower, L. A. (1995) · Nature Genetics · doi:10.1038/ng0395-305 · Cited by 228
p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.
Havre, P. A., Yuan, J., Hedrick, L., Cho, K. R., & Glazer, P. M. (1995) · PubMed · Cited by 223
Human p53 gene localized to short arm of chromosome 17
Miller, C., Mohandas, T., Wolf, D., Prokocimer, M., Rotter, V., & Phillip Koeffler, H. (1986) · Nature · doi:10.1038/319783a0 · Cited by 215
The transactivator proteins VP16 and GAL4 bind replication factor A
He, Z., Brinton, B. T., Greenblatt, J., Hassell, J. A., & Ingles, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90650-f · Cited by 212
Wang, E. H., Friedman, P. N., & Prives, C. (1989) · Cell · doi:10.1016/0092-8674(89)90913-6 · Cited by 207
p53: the ultimate tumor suppressor gene?
Oren, M. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.13.1397838 · Cited by 206
Mouse p53 inhibits SV40 origin-dependent DNA replication
Braithwaite, A. W., Sturzbecher, H.-W., Addison, C., Palmer, C., Rudge, K., & Jenkins, J. R. (1987) · Nature · doi:10.1038/329458a0 · Cited by 205
Truant, R., Xiao, H., Ingles, C. J., & Greenblatt, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53769-8 · Cited by 203
Shaw, P., Freeman, J., Bovey, R., & Iggo, R. D. (1996) · PubMed · Cited by 202
Takenaka, I., Morin, F., Seizinger, B. R., & Kley, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5405 · Cited by 197
p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
Bennett, W. P., Hollstein, M. C., Metcalf, R. A., Welsh, J. A., He, A., Zhu, S., Kusters, I., Resau, J. H., Trump, B. F., & Lane, D. P. (1992) · PubMed · Cited by 196
A single gene and a pseudogene for the cellular tumour antigen p53
Zakut-Houri, R., Oren, M., Bienz, B., Lavie, V., Hazum, S., & Givol, D. (1983) · Nature · doi:10.1038/306594a0 · Cited by 192
Levels of p53 protein increase with maturation in human hematopoietic cells.
Kastan, M. B., Radin, A. I., Kuerbitz, S. J., Onyekwere, O. C., Wolkow, C., Civin, C. I., Stone, K. D., Woo, T. Y., Ravindranath, Y., & Craig, R. W. (1991) · PubMed · Cited by 188
Mammalian p53 can function as a transcription factor in yeast
Schärer, E., & lggo, R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.7.1539 · Cited by 177
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.
Harlow, E., Williamson, N. M., Ralston, R., Helfman, D. M., & Adams, T. E. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.7.1601 · Cited by 174
Zauberman, A., Barak, Y., Ragimov, N., Levy, N., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05941.x · Cited by 173
A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells.
Yanuck, M., Carbone, D., Pendleton, C. D., Tsukui, T., Winter, S. F., Minna, J. D., & Berzofsky, J. A. (1993) · PubMed · Cited by 172
Demers, G. W., Foster, S. A., Halbert, C. L., & Galloway, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4382 · Cited by 172
Inhibition of viral and cellular promoters by human wild-type p53
Subler, M. A., Martin, D. W., & Deb, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4757-4762.1992 · Cited by 171
Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
Iwaya, K., Tsuda, H., Hiraide, H., Tamaki, K., Tamakuma, S., Fukutomi, T., Mukai, K., & Hirohashi, S. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb02710.x · Cited by 171
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.
Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rhodes, N., Tlsty, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., & Kaufmann, W. K. (1995) · PubMed · Cited by 169
Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50
Rotter, V, Witte, O. N., Coffman, R., & Baltimore, D. (1980) · Journal of Virology · doi:10.1128/jvi.36.2.547-555.1980 · Cited by 168
Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.
Benchimol, S., Pim, D. C., & Crawford, L. V. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01296.x · Cited by 168
p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.
Guillouf, C., Rosselli, F., Krishnaraju, K., Moustacchi, E., Hoffman‐Liebermann, B., & Liebermann, D. A. (1995) · PubMed · Cited by 168
Hw, S., Chumakov, P. M., Wj, W., & Jenkins, J. R. (1987) · PubMed · Cited by 163
Involvement of wild-type p53 in pre-B-cell differentiation in vitro.
Shaulsky, G., Goldfinger, N., Peled, A., & Rotter, V (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8982 · Cited by 160
The MCK enhancer contains a p53 responsive element.
Weintraub, H., Hauschka, S., & Tapscott, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4570 · Cited by 159
Soussi, T., de Fromentel, C. C., Méchali, M., May, P., & Kress, M. (1987) · PubMed · Cited by 157
Negative regulation of Rb expression by the p53 gene product.
Shiio, Y., Yamamoto, T., & Yamaguchi, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5206 · Cited by 156
p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
Hw, S., Maimets, T., Chumakov, P. M., Brain, R., Addison, C. M., Simanis, V., Rudge, K., Philp, R. J., Grimaldi, M., & Court, W. J. (1990) · PubMed · Cited by 155
Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases.
Milne, D., Campbell, D. G., Caudwell, F. B., & Meek, D. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37101-6 · Cited by 154
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
Rovinski, B., & Benchimol, S. (1988) · PubMed · Cited by 153
Kelman, Z., Prokocimer, M., PELLER, S., Kahn, Y., Rechavi, G., Manor, Y. S., Cohen, A., & Rotter, V. (1989) · Blood · doi:10.1182/blood.v74.7.2318.2318 · Cited by 151
Crook, T., & Vousden, K. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05487.x · Cited by 148
Borellini, F., & Glazer, R. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53046-5 · Cited by 147
Overproduction of p53 antigen makes established cells highly tumorigenic
Eliyahu, D., Michalovitz, D., & Oren, M. (1985) · Nature · doi:10.1038/316158a0 · Cited by 146
Shay, J. W., Tomlinson, G. E., Piatyszek, M. A., & Gollahon, L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.425 · Cited by 145
Bienz-Tadmor, B., Zakut, R., Libresco, S. M., Givol, D., & Oren, M. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04067.x · Cited by 135
Chang, C., Simmons, D. T., Martı́n, M., & Mora, P. T. (1979) · Journal of Virology · doi:10.1128/jvi.31.2.463-471.1979 · Cited by 133
Cited by
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., et al. (1997) · Science · doi:10.1126/science.275.5298.343 · Cited by 1,183
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Metadata
- Authors
- Harris, C. C.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 1996
- Volume
- 17
- Issue
- 6
- Pages
- 1187-1198
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W1983832776
- Cited by
- 285
- References
- 243
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.